GGrantIndex
← Leaderboards

Alissa M Weaver

Vanderbilt University

$21,443,335
Attributed
$26,242,196
Total exposure
18
Grants
16
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.7M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$35,001,016 · 19

By mechanism

R01$14,142,162 · 6
P01$12,415,370 · 4
U01$3,873,344 · 2
U54$2,818,561 · 2
K22$457,002 · 1
T32$442,933 · 1

Top collaborators

Most similar at Vanderbilt University

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsExtracellular VesiclesProteinsMolecularNeoplasm MetastasisBaseMalignant NeoplasmsPhenotypeIn VivoIn VitroTumorExosomeTumor MicroenvironmentComplexTumor ProgressionTissuesBiogenesisCancer CellCommunicationCell MotilitySiteMediatingAffectBehavior

Grant awards (88)

Exosome secretion in breast cancer progression$453,988
R01 · FY2025 · CA · contact PI
Microenvironmental Influences in Cancer$442,933
T32 · FY2025 · CA
A Turn-Key Single Molecule Localization Microscope for Imaging Extracellular Vesicles and Nanoparticles$397,320
S10 · FY2025 · OD · contact PI
Exosomes in HNSCC Progression$396,575
R01 · FY2025 · CA · contact PI
Regulation of extracellular vesicle biogenesis through cell adhesion$314,925
R01 · FY2025 · CA
exRNA in colorectal carcinoma: biogenesis and function$1,691,857
P01 · FY2024 · CA · contact PI
Regulation of extracellular vesicle biogenesis through cell adhesion$511,050
R01 · FY2024 · CA
Exosomes in HNSCC Progression$470,032
R01 · FY2024 · CA · contact PI
Exosome secretion in breast cancer progression$431,289
R01 · FY2024 · CA · contact PI
Role of ER-membrane contacts in biogenesis of RNA-containing EVs$332,094
P01 · FY2024 · CA · contact PI
EV Purification and Analysis Core$235,555
P01 · FY2024 · CA · contact PI
Administrative Core$149,831
P01 · FY2024 · CA · contact PI
Exosome secretion in breast cancer progression$45,934
R01 · FY2024 · CA · contact PI
exRNA in colorectal carcinoma: biogenesis and function$1,745,006
P01 · FY2023 · CA · contact PI
Regulation of extracellular vesicle biogenesis through cell adhesion$547,930
R01 · FY2023 · CA
Exosome secretion in breast cancer progression$444,908
R01 · FY2023 · CA · contact PI
Role of ER-membrane contacts in biogenesis of RNA-containing EVs$342,580
P01 · FY2023 · CA · contact PI
Exosomes in HNSCC Progression$313,902
R01 · FY2023 · CA · contact PI
EV Purification and Analysis Core$242,993
P01 · FY2023 · CA · contact PI
Administrative Core$154,563
P01 · FY2023 · CA · contact PI
exRNA in colorectal carcinoma: biogenesis and function$1,745,733
P01 · FY2022 · CA · contact PI
Exosome secretion in breast cancer progression$444,905
R01 · FY2022 · CA · contact PI
Phenotype Interactions and Dynamics in SCLC Tumors$420,340
U54 · FY2022 · CA · contact PI
Exosomes in HNSCC Progression$390,429
R01 · FY2022 · CA · contact PI
Phenotype Interactions in SCLC Development and Detection$309,191
U01 · FY2022 · CA · contact PI
Role of ER-membrane contacts in biogenesis of RNA-containing EVs$278,200
P01 · FY2022 · CA · contact PI
Regulation of extracellular vesicle biogenesis through cell adhesion$263,428
R01 · FY2022 · CA
EV Purification and Analysis Core$256,030
P01 · FY2022 · CA · contact PI
Administrative Core$152,708
P01 · FY2022 · CA · contact PI
Outreach Core$104,650
U54 · FY2022 · CA · contact PI
exRNA in colorectal carcinoma: biogenesis and function$1,782,485
P01 · FY2021 · CA · contact PI
Regulation of extracellular vesicle biogenesis through cell adhesion$475,646
R01 · FY2021 · CA
Exosome secretion in breast cancer progression$468,221
R01 · FY2021 · CA · contact PI
Phenotype Interactions and Dynamics in SCLC Tumors$430,496
U54 · FY2021 · CA · contact PI
Exosomes in HNSCC Progression$395,533
R01 · FY2021 · CA · contact PI
Role of ER-membrane contacts in biogenesis of RNA-containing EVs$351,002
P01 · FY2021 · CA · contact PI
Phenotype Interactions in SCLC Development and Detection$315,502
U01 · FY2021 · CA · contact PI
EV Purification and Analysis Core$247,762
P01 · FY2021 · CA · contact PI
Administrative Core$157,471
P01 · FY2021 · CA · contact PI
Outreach Core$116,901
U54 · FY2021 · CA · contact PI
exRNA in colorectal carcinoma: biogenesis and function$1,793,739
P01 · FY2020 · CA · contact PI
Regulation of extracellular vesicle biogenesis through cell adhesion$501,235
R01 · FY2020 · CA
Exosome secretion in breast cancer progression$452,945
R01 · FY2020 · CA · contact PI
Phenotype Interactions and Dynamics in SCLC Tumors$442,768
U54 · FY2020 · CA · contact PI
Role of ER-membrane contacts in biogenesis of RNA-containing EVs$348,504
P01 · FY2020 · CA · contact PI
Phenotype Interactions in SCLC Development and Detection$315,502
U01 · FY2020 · CA · contact PI
EV Purification and Analysis Core$250,034
P01 · FY2020 · CA · contact PI
Administrative Core$157,223
P01 · FY2020 · CA · contact PI
Outreach Core$127,367
U54 · FY2020 · CA · contact PI
International Society for Extracellular Vesicles Annual Meeting$34,310
R13 · FY2020 · TR · contact PI
Phenotype Interactions and Dynamics in SCLC Tumors$471,194
U54 · FY2019 · CA · contact PI
Exosome secretion in breast cancer progression$439,356
R01 · FY2019 · CA · contact PI
Exosome-Filopodia Interactions$384,909
R01 · FY2019 · GM · contact PI
Phenotype Interactions in SCLC Development and Detection$306,036
U01 · FY2019 · CA · contact PI
Exosome-Filopodia Interactions$127,200
R01 · FY2019 · GM · contact PI
Outreach Core$120,673
U54 · FY2019 · CA · contact PI
Phenotype Interactions and Dynamics in SCLC Tumors$464,274
U54 · FY2018 · CA · contact PI
Exosome secretion in breast cancer progression$452,945
R01 · FY2018 · CA · contact PI
Exosome-Filopodia Interactions$384,909
R01 · FY2018 · GM · contact PI
Phenotype Interactions in SCLC Development and Detection$329,752
U01 · FY2018 · CA · contact PI
Exosome-Filopodia Interactions$199,824
R01 · FY2018 · GM · contact PI
Outreach Core$119,898
U54 · FY2018 · CA · contact PI
Exosome secretion in breast cancer progression$452,945
R01 · FY2017 · CA · contact PI
Exosome-Filopodia Interactions$408,366
R01 · FY2017 · GM · contact PI
Exosome-Filopodia Interactions$39,084
R01 · FY2017 · GM · contact PI
Exosome secretion in breast cancer progression$467,195
R01 · FY2016 · CA · contact PI
Exosome-Filopodia Interactions$408,366
R01 · FY2016 · GM · contact PI
Exocytic pathways in HNSCC progression$323,700
R01 · FY2016 · CA · contact PI
Exosome-Filopodia Interactions$91,582
R01 · FY2016 · GM · contact PI
Multiscale Modeling of ECM-tumor interactions in Breast Cancer$461,853
U01 · FY2015 · CA · contact PI
Exocytic pathways in HNSCC progression$323,700
R01 · FY2015 · CA · contact PI
Multiscale Modeling of ECM-tumor interactions in Breast Cancer$447,999
U01 · FY2014 · CA · contact PI
Exocytic pathways in HNSCC progression$313,989
R01 · FY2014 · CA · contact PI
Multiscale Modeling of ECM-tumor interactions in Breast Cancer$434,144
U01 · FY2013 · CA · contact PI
Exocytic pathways in HNSCC progression$304,278
R01 · FY2013 · CA · contact PI
Multiscale Modeling of ECM-tumor interactions in Breast Cancer$461,853
U01 · FY2012 · CA · contact PI
Exocytic pathways in HNSCC progression$323,700
R01 · FY2012 · CA · contact PI
Multiscale Modeling of ECM-tumor interactions in Breast Cancer$491,512
U01 · FY2011 · CA · contact PI
Cortactin function in lamellipodial protrusion$270,802
R01 · FY2011 · GM · contact PI
Cortactin function in lamellipodial protrusion$273,537
R01 · FY2010 · GM · contact PI
Cortactin function in lamellipodial protrusion$276,300
R01 · FY2009 · GM · contact PI
Cortactin function in lamellipodial protrusion$276,300
R01 · FY2008 · GM · contact PI
Cortactin in HNSSC tumor progression$189,764
R21 · FY2008 · DE · contact PI
Cortactin function in lamellipodial protrusion$276,300
R01 · FY2007 · GM · contact PI
Cortactin in HNSSC tumor progression$230,250
R21 · FY2007 · DE · contact PI
Cortactin function in breast cancer metastasis$152,334
K22 · FY2006 · CA · contact PI
Cortactin function in breast cancer metastasis$152,334
K22 · FY2005 · CA
Cortactin function in breast cancer metastasis$152,334
K22 · FY2004 · CA